New Nordic Healthbrands Valuation

Is NNH undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of NNH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate NNH's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate NNH's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for NNH?

Key metric: As NNH is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for NNH. This is calculated by dividing NNH's market cap by their current revenue.
What is NNH's PS Ratio?
PS Ratio	0.2x
Sales	SEK 543.28m
Market Cap	SEK 90.45m

NNH key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.2x
Enterprise Value/EBITDA	-13x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does NNH's PS Ratio compare to its peers?

The above table shows the PS ratio for NNH vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	2.9x
NOSIUM B Nosium	1.5x	n/a	SEK 16.9m
SIMRIS B Simris Group	5.5x	n/a	SEK 25.0m
ELN Ellen	0.4x	n/a	SEK 11.6m
HMPLY Hemply Balance Holding	4.4x	n/a	SEK 7.2m
NNH New Nordic Healthbrands	0.2x	n/a	SEK 90.4m

Price-To-Sales vs Peers: NNH is good value based on its Price-To-Sales Ratio (0.2x) compared to the peer average (2.9x).

Price to Sales Ratio vs Industry

How does NNH's PS Ratio compare vs other companies in the European Personal Products Industry?

8 Companies	Price / Sales	Estimated Growth	Market Cap
Industry Avg.	1.4x	4.7%
NNH New Nordic Healthbrands	0.2x	n/a	US$8.22m

8 Companies		Estimated Growth	Market Cap
Industry Avg.	1.4x	8.0%
NNH New Nordic Healthbrands	0.2x	n/a	US$8.22m

No more companies

Price-To-Sales vs Industry: NNH is good value based on its Price-To-Sales Ratio (0.2x) compared to the European Personal Products industry average (1.4x).

Price to Sales Ratio vs Fair Ratio

What is NNH's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NNH PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.2x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate NNH's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.